The world’s largest animal health business is starting to take shape with the announcement of a name and a chief executive for the new company.
The joint venture business formed by the French multinational sanofi-aventis and Merck & Co , headquartered in the US, combines sanofi-aventis’ Merial with ...
Merial has announced a collaboration with another biopharmaceutical development company which aims to develop innovative vaccines for veterinary use.
The company has signed an agreement with Biolex Therapeutics of Pittsburgh, North Carolina which it describes as a "broad-ranging research and ...
MAF Biosecurity New Zealand (MAFBNZ) has extended its contract with a French manufacturer of foot and mouth (FMD) disease antigen and vaccine.
MAFBNZ director post border,
Peter Thomson
, said the contract has been renewed for a further five years and is an agreement MAFBNZ has had in place since ...
Merial has reached an agreement with a non-profit biotechnology research organisation in the US to develop veterinary vaccines for companion animals. It says the move will help to create vaccines to fill the many unmet need that still exist, particularly in protecting the human population from the ...
For the first time in Japan since April 2009, there has been an outbreak of Newcastle disease. The World Organisation for Animal Health (OIE ) confirmed that the outbreak began on the 28th of June on a farm consisting of 58 birds. Thirty-three of these chicks died from this disease, and the ...
